MedDataX Logo

Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients

NCT ID: NCT00279656

Last Updated: 2006-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-11-30

Study Completion Date

2005-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the impact of a collaborative approach (geriatric care involving the collaboration with a clinical pharmacist) to optimize the prescription of medicines for elderly inpatients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Widespread evidence reveals frequent inadequate use of medicines in elderly patients. This includes inappropriate prescribing (overuse, underuse, misuse) that can lead to adverse drug events and drug-related admissions to hospital. In addition, when a patient is transferred from acute care settings to ambulatory care settings, discrepancies in medicines used often occur and can be hazardous.

Despite this, only limited data exist on the effectiveness of optimization strategies targeted at frail elderly inpatients.

Comparison: elderly inpatients receiving geriatric evaluation and management (GEM) care versus elderly inpatients receiving pharmaceutical care in addition to GEM care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frail Elderly Inpatient

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Frail elderly Pharmaceutical services Drug therapy Geriatrics Randomized controlled trial Hospitals, teaching

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

ECT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pharmaceutical care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient admitted on the acute geriatric unit of the university teaching hospital Mont-Godinne, Belgium

Exclusion Criteria

* a terminal illness and life expectancy of less than 3 month
* expected length of stay of 2 days or less
* transfer from another unit where the patient had already been cared for by a GEM team
* refusal to participate
* inclusion during previous admission
* no time for the clinical pharmacist to compound the abstracted chart within 3 days of admission
Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fonds National de la Recherche Scientifique

OTHER

Sponsor Role collaborator

Université Catholique de Louvain

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne Spinewine, MSc

Role: PRINCIPAL_INVESTIGATOR

Université Catholique de Louvain

Christian Swine, MD

Role: STUDY_CHAIR

Université Catholique de Louvain

Paul M Tulkens, PhD

Role: STUDY_DIRECTOR

Université Catholique de Louvain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Université catholique de Louvain

Brussels, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

om050-40/2003

Identifier Type: -

Identifier Source: org_study_id